The American Society of Dermatopathology

Short Courses

Your registration to the ASDP Virtual Annual Meeting includes admission to the Short Courses.

  • Short Course I
    Immunohistochemistry for Dermatopathologists: Current Perspectives
  • Short Course II
    Common Quandaries: How Do Your Diagnoses and Approach Compare with the Audience and Our Expert Panel?
  • Short Course III
    Alopecia: Practical Tips and Literature Updates

Short Course I

Immunohistochemistry for Dermatopathology: Current Perspectives

Thursday, November 5
9:00 a.m. - 12:30 p.m. Central Time

Course Director
Gregory A. Hosler, MD, PhD
ProPath

AMA PRA Category 1 CreditsTM 

Immunohistochemistry has been used as an ancillary study in dermatopathology for decades, but the technique, its uses, and our experience in interpretation continue to evolve. This course will provide current and practical insight on using immunohistochemistry in a dermatopathology practice.

Faculty and Course Outline
 
9:00 a.m. - 9:05 a.m.

 
Introduction
Gregory A. Hosler, MD, PhD
ProPath
9:05 a.m. - 9:35 a.m.

 
Overview of Immunohistochemistry
Marc R. Lewin, MD
ProPath
9:35 a.m. - 10:05 a.m.

 
Practical Panels, Pearls and Pitfalls I: Epithelial Tumors
Mai P. Hoang, MD
Massachusetts General Hospital and Harvard Medical School
10:05 a.m. - 10:30 a.m. Break
10:30 a.m. - 11:00 a.m.

 
Practical Panels, Pearls and Pitfalls II: Lymphoma
Alexandra C. Hristov, MD
University of Michigan
11:00 a.m. - 11:30 p.m.

 
Practical Panels, Pearls and Pitfalls III: Soft Tissue
Konstantinos Linos, MD
Dartmouth Hitchcock Medical Center and Geisel School of Medicine at Dartmouth
11:30 a.m. - 12:00 p.m.

 
Emerging Uses
Travis J. Hollman, MD, PhD
Memorial Sloan Kettering Cancer Center
12:00 p.m. - 12:30 p.m. Q & A and Closing Remarks

Learning Objectives:
Upon completion of this course, participants should be able to:
  • Identify current and emerging uses for immunohistochemistry.
  • Describe three practical immunopanels for commonly encountered dilemmas and recognize pitfalls one may encounter in dermatopathology.
  • Apply immunohistochemistry as biomarkers to increase diagnostic accuracy, and improve patient care and outcome

Short Course II

Common Quandaries: How Do Your Diagnoses and Approach Compare with the Audience and Our Expert Panel?

Saturday, November 7
8:00 a.m. - Noon Central Time

Course Director
Catherine G. Chung, MD
The Ohio State University Wexner Medical Center

Thomas N. Helm, MD
Buffalo Medical Group
 
3.5 AMA PRA Category 1 CreditsTM

Back by popular demand! This course was initially offered during the ASDP 55th Annual Meeting and returns this year with a whole new set of quandaries and a new panel of experts. Attempting to simulate an atmosphere of a professor’s sign-out with his/her students by allowing attendees to compare their diagnoses and approaches to challenging and/or ambiguous cases with those of the panelists.

This year’s topics will include:
  • Best practices for reporting of margins – e.g., how do you handle the reporting of an infiltrative basal cell carcinoma that extends to within 0.2 mm of the examined inked margin? - (recommend re-excision, report distance to margin, etc.)
  • Best practices for communicating diagnoses for histologically ambiguous lesions – and which additional clinical factors should be taken into consideration.
  • Explore trigger points that prompt malignant vs. benign diagnoses for keratinocytic, lymphoproliferative, and melanocytic proliferations.
  • When to request newer molecular technologies 
  • How to appropriately handle inadequate specimens in a variety of situations.
  • Ethical conundrums that arise in everyday situations.
Faculty

Steven D. Billings, MD
Cleveland Clinic
 
Tammie C. Ferringer, MD
Geisinger Medical Center
 
Lawrence E. Gibson, MD
May Clinic, Rochester
 
Whitney A. High, JD, MD, MEng
University of Colorado
 
Jinah Kim, MD, PhD
Stanford University
 
Christine J. Ko, MD
Yale University
 
Melissa Pulitzer, MD
Memorial Sloan Kettering Cancer Center
 
Beth S. Ruben, MD
Palo Alto Medical Foundation
 
Iwei Yeh, MD, PhD
University of California, San Francisco

Learning Objectives:
Upon completion of this course, participants should be able to:
  • Identify and address professional practice gaps in the handling of routine cases.
  • Demonstrate greater understanding and increased diagnostic accuracy of challenging and/or ambiguous cases.

Short Course III

Alopecia: Practical Tips and Literature Updates

Wednesday, November 11
8:00 a.m. – 12:30 p.m. Central Time

Course Directors
Eleanor A. Knopp, MD
Kaiser Permanente of Washington and University of Washington
 
4 AMA PRA Category 1 CreditsTM
 
This course will cover all things alopecia, including practical tips and best practices for routine diagnoses as well as updates and emerging concepts, with a focus on clinical differential diagnoses relevant for the dermatopathologist. Updates in the basic science of LPP/FFA and CCCA, medication-associated and multifactorial alopecia will also be discussed.
 
Faculty and Course Outline
   
8:00 a.m. 8:05 a.m.

 
Introduction
Eleanor A. Knopp, MD
Kaiser Permanente of Washington and University of Washington
SKILLS BUILDING  
8:05 a.m. 8:45 a.m.

 
I. Biopsy Interpretation: The Fundamentals
Eleanor A. Knopp, MD
Kaiser Permanente of Washington and University of Washington
8:45 a.m. - 10:00 a.m. II. Differential Diagnoses by Pattern Clusters
8:45 a.m.  9:10 a.m.

 
A. Clinical Differential Diagnostic Clusters
Leonard C. Sperling, MD
Uniformed Services University of the Health Sciences
9:10 a.m. - 10:00 a.m.

 
B. Histologic Differential Diagnostic Clusters
Shawn E. Cowper, MD
Yale University
10:00 a.m. - 10:30 a.m. Break
10:30 a.m. - 11:00 a.m.

 
III. Mulitfactorial Alopecia
Leonard C. Sperling, MD
Uniformed Services University of the Health Sciences
WHAT'S NEW  
11:00 a.m. - 11:30 a.m.

 
IV. Evolving Concepts in Alopecia
Lynne J. Goldberg, MD
Boston University School of Medicine
11:30 a.m. - 12:00 p.m.

 
V. Drug-Associated Alopecia: All that Glitters is Not Gold
Catherine M. Stefanato, MD
St John's Institute of Dermatology
12:00 p.m. - 12:30 p.m. Q & A

Learning Objectives:
Upon completion of this course, participants should be able to:
  • Identify more than one diagnostic entity in a single specimen.
  • Demonstrate greater understanding of key features of permanent chemotherapy-induced alopecias.
  • Discern differential diagnostic categories and distinguishing features that can help refine diagnostic reports, and improve patient care and outcomes.
  • Describe advances in the understanding of the pathogenesis of CCCA and LPP.
  • Identify medications known to cause or exacerbate specific alopecias in order to improve patient care.